Company Filing History:
Years Active: 2023
Title: Doug Daniels - Innovator in PCSK9 Inhibitors
Introduction
Doug Daniels is a prominent inventor based in Oakwood, OH (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of PCSK9 inhibitors. His innovative work has the potential to impact the treatment of various cardiovascular diseases.
Latest Patents
Doug Daniels holds 1 patent related to his invention of PCSK9 inhibitors and methods of use thereof. This invention focuses on a novel inhibitor pharmacophore of PCSK9 and heteroaryl compounds that bind the PCSK9 protein. This advancement is crucial in the ongoing efforts to manage cholesterol levels and improve heart health.
Career Highlights
Doug is currently employed at AstraZeneca, a leading global biopharmaceutical company. His role involves research and development in the area of cardiovascular treatments. His expertise and innovative mindset have positioned him as a valuable asset to the company.
Collaborations
Throughout his career, Doug has collaborated with notable colleagues, including Michael H Serrano-Wu and Brian K Hubbard. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Doug Daniels is a key figure in the development of PCSK9 inhibitors, with a focus on innovative solutions for cardiovascular health. His contributions to the field are noteworthy and demonstrate the importance of continued research in this area.